Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gefitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03050164
What this trial is testing

Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions

Who this might be right for
Bioequivalence Study
Hunan Kelun Pharmaceutical Co., Ltd. 38
Testing effectiveness (Phase 2)Study completedNCT00062062
What this trial is testing

Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 65
Testing effectiveness (Phase 2)UnknownNCT04358562
What this trial is testing

Gefitinib With Anlotinib in Advanced Non-squamous NSCLC Patients With Uncleared Plasma ctDNA EGFRm After First-line Treatment With Gefitinib

Who this might be right for
Non-small Cell Lung CancerEGFR Gene Mutation
Second Affiliated Hospital of Nanchang University 240
Testing effectiveness (Phase 2)Study completedNCT01039948
What this trial is testing

A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell-LungLung NeoplasmsLung Cancer+1 more
AVEO Pharmaceuticals, Inc. 203
Testing effectiveness (Phase 2)Study completedNCT03758287
What this trial is testing

Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative

Who this might be right for
Non-small Cell Lung Cancer
Sunshine Lake Pharma Co., Ltd. 108
Large-scale testing (Phase 3)Study completedNCT02296125
What this trial is testing

AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
AstraZeneca 674
Large-scale testing (Phase 3)UnknownNCT03849768
What this trial is testing

Evaluate Safety and Efficacy of HS-10296 as First-Line Treatment in Patients

Who this might be right for
Non Small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 429
Large-scale testing (Phase 3)Ended earlyNCT00234468
What this trial is testing

Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

Who this might be right for
Non Small Cell Lung Carcinoma
AstraZeneca 490
Testing effectiveness (Phase 2)Ended earlyNCT00479089
What this trial is testing

Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00231465
What this trial is testing

Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 44
Testing effectiveness (Phase 2)Study completedNCT01185171
What this trial is testing

Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head & Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Chicago 70
Testing effectiveness (Phase 2)Study completedNCT00711594
What this trial is testing

LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 74
Not applicableStudy completedNCT03157310
What this trial is testing

Bone Metastasis on the Survival of Gefitinib Effective Patients

Who this might be right for
Overal Survival, Non-small Cell Lung Cancer
Qilu Hospital of Shandong University 265
Testing effectiveness (Phase 2)UnknownNCT00319800
What this trial is testing

Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Gachon University Gil Medical Center 50
Large-scale testing (Phase 3)UnknownNCT00955695
What this trial is testing

Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Cancer Center, Korea 242
Early research (Phase 1)Study completedNCT01121575
What this trial is testing

Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Pfizer 70
Large-scale testing (Phase 3)Study completedNCT00049543
What this trial is testing

Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+6 more
National Cancer Institute (NCI) 503
Testing effectiveness (Phase 2)Study completedNCT01185158
What this trial is testing

A Phase II Study of 250-mg ZD1839 Monotherapy in Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
University of Chicago 46
Testing effectiveness (Phase 2)Study completedNCT00246974
What this trial is testing

Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT

Who this might be right for
Bladder Cancer
AstraZeneca 125
Testing effectiveness (Phase 2)Study completedNCT00030524
What this trial is testing

ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
The University of Texas Health Science Center at San Antonio
Next Page